Search research articles
Contact Us
Filters
Showing results (91-100 of 102) with videos related to
Page
of 11
Sort By:
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2026
Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
Manish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Journal of Personalized Medicine
|
December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
Brian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma
Abdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases
Preeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Cancer Cell
|
January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
Salvador Alonso, Kanwal Raghav, Van K Morris, et al.
NPJ Systems Biology and Applications
|
December 12, 2025
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response
Brian De, Prashant Dogra, Mohamed Zaid, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response
Brian De, Prashant Dogra, Mohamed Zaid, et al.
Cancer Discovery
|
July 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Kanwal Raghav, Suyu Liu, Michael J Overman, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 102) with videos related to
Sort By:
Page
of 11
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 15, 2026
Erratum: Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors
Manish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
Journal of Personalized Medicine
|
December 24, 2021
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma
Brian De, Ibrahim Abu-Gheida, Aashini Patel, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 25, 2023
The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma
Abdelrahman Yousef, Mahmoud Yousef, Mohammad Zeineddine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 3, 2021
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases
Preeti Kanikarla Marie, Cara Haymaker, Edwin Roger Parra, et al.
Oncology
|
October 7, 2020
Impact of Integrating Insulin-Like Growth Factor 1 Levels into Model for End-Stage Liver Disease Score for Survival Prediction in Hepatocellular Carcinoma Patients
Reham Abdel-Wahab, Manal M Hassan, Bhawana George, et al.
Cancer Cell
|
January 9, 2026
Framework for cancer evolution profiling and interception in colorectal cancer: ASCEND-CRC program
Salvador Alonso, Kanwal Raghav, Van K Morris, et al.
NPJ Systems Biology and Applications
|
December 12, 2025
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response
Brian De, Prashant Dogra, Mohamed Zaid, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 24, 2024
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response
Brian De, Prashant Dogra, Mohamed Zaid, et al.
Cancer Discovery
|
July 15, 2021
Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma
Kanwal Raghav, Suyu Liu, Michael J Overman, et al.
Page
of 11